Michael Albert MD’s Post

View profile for Michael Albert MD, graphic

Co-Founder & Chief Medical Officer at Accomplish Health | Healthcare Futurist | Clinical Assistant Professor of Medicine - OUHSC

The new cardiometabolic drugs (GLP1s and other hormone-based therapies) are getting more potent in their ability to ameliorate suffering, but with great potential also comes great responsibility. I cannot emphasize this enough: you MUST NOT casually prescribe these meds. This will lead to adverse events. If you are interested in therapy, please work with expert clinics like Accomplish Health and others. [1] Rise in GLP1 overdoses — https://lnkd.in/guHemEfE [2] Adverse GI events linked to GLP1 meds — https://lnkd.in/gJ_fRkBe [3] EMA investigating link between GLP1 meds and suicidal ideation — https://lnkd.in/g5rWpxzW

GLP-1 Agonists and Gastrointestinal Adverse Events

GLP-1 Agonists and Gastrointestinal Adverse Events

jamanetwork.com

Nicki Armstrong

Nurse Practitioner at Vital Surgical Specialists

10mo

Yes, patients need a lot of teaching & coaching to successfully navigate the normal, expected side effects (as well vigilance for adverse effects).

Like
Reply
Mark Player, MD, PhD, FRSC

Principal at Sawgrass MedChem Consulting | Experienced Drug Hunter & Cross-functional Scientific Team Leader

10mo

Good to hear about the review of potential suicidal ideation. We must not forget the lessons from CB1 inverse agonists (rimonabant et al.).

Like
Reply
Dr Meghanath Yenni

Consultant Physician @ Medicover Hospitals | Internal Medicine. Avid Writer on Medical,Social and Geo-political issues. Medico-Legal Expert

10mo

The excitement and noise about weight loss has silenced all the discussion about side effects; though minor but significant..!!

Alessandro (Ale) Pocai

Sr Director @ Johnson & Johnson | Scientific Strategy & Innovation (CV/PH, Metabolism/obesity)

10mo

Important reminder

See more comments

To view or add a comment, sign in

Explore topics